India’s Goods and Services Tax (GST) Council recently announced a significant reduction in levies on medical device GST and diagnostics. This pivotal move aims to enhance healthcare affordability and accessibility across the nation. Finance Minister Nirmala Sitharaman confirmed that most medical, surgical, dental, and veterinary devices, previously taxed at 18%, now fall under a 5% GST bracket. Furthermore, essential items like wadding gauze, bandages, diagnostic kits, reagents, and glucometers will also see their GST reduced from 12% to 5%. Consequently, healthcare leaders nationwide are reacting very positively to these revisions. [4, 5]
Industry experts widely view these changes as a transformative step. They anticipate lower out-of-pocket expenses for patients and a substantial boost for the diagnostics and medical device sectors. While some experts note potential operational challenges, the overall sentiment remains highly optimistic. Dr. Harsh Mahajan, Founder & Chairman of Mahajan Imaging & Labs, expressed hope for a similar GST reduction on equipment maintenance service contracts. He explained that hospitals currently do not receive input tax credit on GST paid for essential items. This often increases patient costs due to embedded taxes.
Impact of Medical Device GST on Patient Costs
The reduction in GST rates carries wide-ranging implications for India’s healthcare sector. Importantly, the overall decrease on drugs, consumables, equipment, and life-saving medicines will significantly lower treatment costs. This eases the financial burden on patients and provides direct savings to hospitals. [3, 10] Diabetes affects nearly 10% of India’s adult population. As non-communicable diseases rise, cheaper glucometers and test strips will further support early detection. [6] Moreover, this aligns perfectly with the government’s focus on preventive healthcare initiatives. Therefore, better access to diagnostic tools means more people can monitor their health proactively. [5, 11] A strong understanding of diabetes management is crucial for healthcare professionals. Our International Post Graduate Program In Diabetes Mellitus Management offers comprehensive training in this area.
Ameera Shah, President of NATHEALTH, emphasized that these reforms validate the critical role of preventive care and affordability. She noted that this measure strengthens healthcare delivery by easing costs and improving access to quality services. Furthermore, it supports early disease detection. It also brings greater consistency by standardizing GST rates across preventive, curative, and rehabilitative care. This holistic approach ensures broader benefits for patients across various healthcare needs. [3, 6]
Medical Device GST and “Make in India”
Jatin Mahajan, President of the Association of Diagnostics Manufacturers of India (ADMI), highlighted the boost for affordability and the “Make in India” initiative. Bringing medical devices, including diagnostic equipment and test kits, into a uniform 5% slab will meaningfully cut out-of-pocket costs for patients. Consequently, this accelerates screening, early detection, and treatment nationwide. [8] Equally important, a simpler two-rate structure reduces compliance friction. It also eases working-capital pressures. This encourages investment in quality, R&D, and export readiness, which are key pillars for ‘Make in India’ in diagnostics. The industry stands ready to pass through these gains and expand access to advanced diagnostic solutions. [5, 6] For professionals looking to deepen their understanding of diagnostic procedures, the Certification Course In Clinical Imaging provides valuable insights.
Monika Arora, Partner at Deloitte India, affirmed improved affordability but also raised concerns regarding working capital and duty inversion. Specifically, higher GST rates (18%) on Active Pharmaceutical Ingredients (APIs) contrast with reduced rates (Nil or 5%) on finished formulations. This could lead to enhanced working capital pressure. However, the GST Council addressed this by recommending a 90% provisional refund on claims arising from such inverted duty structures. This mechanism aims to mitigate potential negative impacts effectively. [4, 9]
Frequently Asked Questions
Q1: What is the primary change announced by the GST Council regarding medical devices?
A: The GST Council significantly reduced the tax slabs for most medical, surgical, dental, and veterinary devices from 18% to 5%. Additionally, diagnostic kits, reagents, and glucometers now fall from 12% to 5%. [4, 5]
Q2: How will these GST revisions impact patients and hospitals?
A: These revisions are expected to lower treatment costs, reduce out-of-pocket expenditure for patients, and provide direct savings to hospitals. They also support early detection and better disease management, particularly for conditions like diabetes. [3, 6, 7] Understanding the management of specific diseases is vital. For instance, those interested in pediatric diabetes can explore the Certification Course in Managing Type 2 Diabetes in Children and Young People.
Q3: Are there any concerns associated with these GST rate changes?
A: While generally positive, some experts, like Monika Arora from Deloitte India, have raised concerns about enhanced working capital pressure. This pressure arises from duty inversion (higher GST on APIs vs. lower on finished products). However, the Council has recommended a 90% provisional refund to address this issue effectively. [4, 9]
References
- Tax slabs slashed for medical devices and diagnostics by GST Council – ETHealthworld
- GST Council slashes rates on medical devices, diagnostic kits to 5%; industry hails move – The Economic Times
- Lower GST to make medicines and medical devices more affordable – Times of India
- Centre reduces GST on medical equipment from 12% to 5%
- Govt recommends GST reduction from 12% to 5% on various medical equipment and supplies devices – BioSpectrum India
- How GST cuts will bridge India’s health equity gap – Healthcare Radius
- GST Rate Cuts Make Medicine Affordable, Insurance Accessible: Apollo Hospital’s Shobana Kamineni – NDTV Profit
- Medical devices industry welcomes GST rate cut, raises various concerns – Pharmabiz.com
- GST rate cut updates: New GST rates, applicable date, slab changes, impact, rules and FAQs – Upstox
- GST cut on drugs, medical devices to provide relief to patients: Industry players
- GST Revamp: What’s Cheaper, Costlier? See Full List Here
- Prices of diagnostic tests unlikely to change much despite GST rate cut – Business Standard
- Individual Life And Health Insurance Policies To Be Exempt From GST – NDTV
- Insurance GST cut to zero: Save ₹2700 annually on ₹15000 premium | Personal Finance
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.